Agoracom: Small Cap Investment - Zenith Epigenetics - Re: The crick didn’t rise, here’s the presentation, finally!

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Back To Forum List View

The crick didn’t rise, here’s the presentation, finally!

jbuffett62

Oct 27, 2023 05:31PM

Re: The crick didn’t rise, here’s the presentation, finally!

fuzzyjr

Oct 27, 2023 06:54PM

Re: The crick didn’t rise, here’s the presentation, finally!

fuzzyjr

Oct 27, 2023 07:01PM

Re: The crick didn’t rise, here’s the presentation, finally!

jonzobot

Oct 28, 2023 11:44AM

fuzzyjr

Rank: Vice President [?]

Points: 5268 [?]

Votes: 36 Score: 3.1 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: The crick didn’t rise, here’s the presentation, finally!

in response to

Re: The crick didn’t rise, here’s the presentation, finally!

jonzobot

posted on Oct 28, 2023 01:14PM

I respectfully disagree Jonzo - your more or less saying Don buffaloed Cencora - IMO Cencora see's the potential here & it's my belief now that we will see a deal of sorts within the next 3 to 6 months & that deal may not even be with Cencora in the end. Time will tell.

glta

2 Recommendations